Advances in Pharmacological Sciences最新文献

{"title":"Combined Inositol Hexakisphosphate and Inositol Supplement Consumption Improves Serum Alpha-Amylase Activity and Hematological Parameters in Streptozotocin-Induced Type 2 Diabetic Rats","authors":"S. Foster, L. Dilworth, J. Sparks, R. Alexander-Lindo, F. Omoruyi","doi":"10.1155/2019/4143137","DOIUrl":"https://doi.org/10.1155/2019/4143137","url":null,"abstract":"This study evaluated the effect of combined inositol hexakisphosphate (IP6) and inositol supplement on organ weight, intestinal ATPase activities, complete blood count, and serum analytes in streptozotocin (STZ)-induced type 2 diabetic rats. High-fat diet and a single intraperitoneal injection of streptozotocin (35 mg/kg body weight) were used to induce type 2 diabetes mellitus in Sprague–Dawley rats. The diabetic groups were then treated with either combined IP6 and inositol supplement or glibenclamide for four weeks. Organ weights, intestinal ATPase activities, complete blood count, serum α-amylase, total protein, albumin, and globulin content were determined. Pancreatic weight was significantly reduced while relative kidney and liver weights were elevated in the group treated with combined IP6 and inositol supplement compared to the nondiabetic control. Serum α-amylase activity for the glibenclamide and combination treated groups was significantly improved compared to that of the untreated diabetic group. Red cell distribution width percentage was significantly lower in the combination treated group compared to that in the untreated diabetic group, while intestinal ATPase activities were unaffected by the treatment regime. Combined IP6 and inositol supplement consumption may protect people with diabetes from increased risk of cardiovascular diseases due to the supplement's ability to maintain red cell distribution width percentage towards the normal control group.","PeriodicalId":7389,"journal":{"name":"Advances in Pharmacological Sciences","volume":"2019 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2019/4143137","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42837381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Protective Effects of Aqueous Extract of Baillonella toxisperma Stem Bark on Dexamethasone-Induced Insulin Resistance in Rats","authors":"Marius Trésor Wego, S. L. Poualeu Kamani, D. Miaffo, M. L. Nchouwet, A. Kamanyi, S. L. Wansi Ngnokam","doi":"10.1155/2019/8075163","DOIUrl":"https://doi.org/10.1155/2019/8075163","url":null,"abstract":"The aim of this study was to evaluate the effects of the aqueous extract of Baillonella toxisperma stem bark on dexamethasone-induced insulin resistance in rats. A quantitative phytochemical study was done on the aqueous extract of Baillonella toxisperma for the total phenol, flavonoid, and flavonol determination. Insulin resistance was induced by intraperitoneal injection of dexamethasone (1 mg/kg) for 8 days, one hour before oral administration of different treatments (extract at doses of 60, 120, and 240 mg/kg and metformin at 40 mg/kg). During the test, body weight and blood glucose level were evaluated on days 1 and 8. At the last day of treatment, the glucose tolerance test was performed in rats; after that, blood samples were collected for triglycerides, total cholesterol, LDL and HDL cholesterols, transaminases (ALT and AST), and total protein level determination. Organs (heart, liver, pancreas, and kidneys) were also collected for the relative organ weight determination. The results showed that the aqueous extract of B. toxisperma is rich in total phenols, flavonoids, and flavonols. This extract significantly reversed the metabolic alterations (lipid profile, protein level, and transaminase activity) induced by dexamethasone in rats. At doses of 120 and 60 mg/kg, Baillonella toxisperma also significantly decreases (p < 0.05; p < 0.01) postprandial hyperglycemia in insulin resistance rats. The results suggest that Baillonella toxisperma can manage insulin resistance and may be useful for the treatment of type 2 diabetes mellitus.","PeriodicalId":7389,"journal":{"name":"Advances in Pharmacological Sciences","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2019/8075163","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49483521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effect of Calcium and Vitamin D Supplements as an Adjuvant Therapy to Metformin on Menstrual Cycle Abnormalities, Hormonal Profile, and IGF-1 System in Polycystic Ovary Syndrome Patients: A Randomized, Placebo-Controlled Clinical Trial","authors":"Sally Kadoura, M. Alhalabi, A. Nattouf","doi":"10.1155/2019/9680390","DOIUrl":"https://doi.org/10.1155/2019/9680390","url":null,"abstract":"Objective This study aims to investigate the effect of combining calcium and vitamin D supplements with metformin on menstrual cycle abnormalities, gonadotropins, and IGF-1 system in vitamin D-deficient/insufficient PCOS women. Study Design This is a randomized, placebo-controlled clinical trial. Setting This study was performed in Damascus University of Obstetrics and Gynecology Hospital and Orient Hospital, in Damascus, Syria. Materials and Methods Forty PCOS women with 25-OH-vitamin D < 30 ng/ml were randomly assigned to take either metformin (1500 mg/daily) plus placebo or metformin (1500 mg/daily) plus calcium (1000 mg/daily) and vitamin D3 (6000 IU/daily) orally for 8 weeks. Serum levels of gonadotropins (luteinizing hormone (LH) and follicle-stimulating hormone (FSH)), insulin-like growth factor-1 (IGF-1), and insulin-like growth factor binding protein-1 (IGFBP-1) were detected at the baseline during the early follicular phase of a spontaneous or induced menstrual cycle and after 8 weeks of intervention (except for the final gonadotropins levels which were assayed from samples obtained during the early follicular phase of a spontaneous menstrual cycle). Results Thirty-four patients (85%) completed the study. After 8 weeks of intervention, calcium and vitamin D co-supplementation led to a significant increase in 25-OH-vitamin D levels and calcium levels in the supplementation group compared to the other group (change in 25-OH-vitamin D levels: +19.38 ± 7.78 vs +0.11 ± 4.79 ng/ml, respectively; p value=0.0001) (change in calcium levels: +0.83 ± 0.82 vs +0.01 ± 0.86 mg/dl, respectively; p value=0.014). An improvement in menstrual cycle irregularity was detected in 38.5% and 58.8% of patients in metformin-placebo group and metformin-calcium-vitamin D group, respectively; but the change was statistically significant only in the supplementation group (p value=0.002). Nevertheless, the means of changes from baseline in gonadotropins levels (serum levels of LH, FSH, and LH to FSH ratio) and the studied parameters of IGF-1 system (serum levels of IGF-1, IGFBP-1, and IGF-1 to IGFBP-I ratio) did not differ significantly between the two groups. Conclusions Calcium and vitamin D supplements can support metformin effect on regulation of menstrual cycle irregularity in vitamin D-deficient/insufficient PCOS patients, but this effect is not associated with any significant changes in gonadotropins or IGF-1 system. These results suggest a possible role of calcium and vitamin D supplements in managing PCOS. However, further studies are needed to identify the underlying mechanisms. The Clinical Trial Registration Number is NCT03792984.","PeriodicalId":7389,"journal":{"name":"Advances in Pharmacological Sciences","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2019/9680390","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45793796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluation of Anti-HIV-1 Integrase and Anti-Inflammatory Activities of Compounds from <i>Betula alnoides</i> Buch-Ham.","authors":"Prapaporn Chaniad,&nbsp;Teeratad Sudsai,&nbsp;Abdi Wira Septama,&nbsp;Arnon Chukaew,&nbsp;Supinya Tewtrakul","doi":"10.1155/2019/2573965","DOIUrl":"https://doi.org/10.1155/2019/2573965","url":null,"abstract":"<p><p><i>Betula alnoides</i> is a medicinal plant in Thai traditional longevity preparations. The crude extracts of this plant possess various biological activities. However, the isolated compounds from this plant have no reports of anti-HIV-1 integrase (IN) activity. Therefore, the present study aims to investigate the anti-HIV-1 integrase and anti-inflammatory effects of isolated compounds from this plant and predict the interaction of compounds with integrase active sites. From the bioassay-guided fractionation of the ethanol extract of <i>B. alnoides</i> stems using chromatographic techniques, five pentacyclic triterpenoid compounds were obtained. They are betulinic acid (<b>1</b>), betulin (<b>2</b>), lupeol (<b>3</b>), oleanolic acid (<b>4</b>), and ursolic acid (<b>5</b>). Compound <b>2</b> exhibited the most potent inhibitory activity against HIV-1 IN, with an IC₅₀ value of 17.7 <i>μ</i>M. Potential interactions of compounds with IN active sites were investigated using computational docking. The results indicated that active compounds interacted with Asp64, a residue participating in 3'-processing, and Thr66, His67, and Lys159, residues participating in strand-transfer reactions of the integration process. Regarding anti-inflammatory activity, all compounds exerted significant inhibitory effects on LPS-induced nitric oxide production (IC₅₀ < 68.7 <i>μ</i>M). Thus, this research provides additional scientific support for the use of <i>B. alnoides</i> in traditional medicine for the treatment of HIV patients.</p>","PeriodicalId":7389,"journal":{"name":"Advances in Pharmacological Sciences","volume":"2019 ","pages":"2573965"},"PeriodicalIF":0.0,"publicationDate":"2019-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2019/2573965","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37392489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Nature-Inspired Drugs: Expanding Horizons of Contemporary Therapeutics.","authors":"Azhar Rasul,&nbsp;Ghulam Hussain,&nbsp;Zeliha Selamoglu,&nbsp;Maria P López-Alberca","doi":"10.1155/2019/6218183","DOIUrl":"https://doi.org/10.1155/2019/6218183","url":null,"abstract":"","PeriodicalId":7389,"journal":{"name":"Advances in Pharmacological Sciences","volume":"2019 ","pages":"6218183"},"PeriodicalIF":0.0,"publicationDate":"2019-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2019/6218183","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37325084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Synthesis of an Activatable Tetra-Substituted Nickel Phthalocyanines-4(3H)-quinazolinone Conjugate and Its Antibacterial Activity.","authors":"Asma M Elsharif,&nbsp;Tamer E Youssef,&nbsp;Suhailah S Al-Jameel,&nbsp;Hanan H Mohamed,&nbsp;Mohammad Azam Ansari,&nbsp;Suriya Rehman,&nbsp;Sultan Akhtar","doi":"10.1155/2019/5964687","DOIUrl":"10.1155/2019/5964687","url":null,"abstract":"<p><p>The aim of this study was to synthesize a series of nickel(II)phthalocyanines (NiPcs) bearing four 4(3H)-quinazolinone ring system units, (qz)₄NiPcs <b>4a-d</b>. The electronic factors in the 4(3H)-quinazolinone moiety that attached to the NiPc skeleton had a magnificent effect on the antibacterial activity of the newly synthesized (qz)₄NiPcs <b>4a-d</b> against <i>Escherichia coli</i>. The minimum MICs and MBCs value were recorded for compounds <b>4a</b>, <b>4b</b>, <b>4c</b>, and <b>4d</b>, respectively. The results indicated that the studied (qz)₄NiPcs <b>4a-d</b> units possessed a broad spectrum of activity against <i>Escherichia coli</i>. Their antibacterial activities were found in the order of <b>4d</b> > <b>4c</b> > <b>4b</b> > <b>4a</b> against <i>Escherichia coli</i>, and the strongest antibacterial activity was achieved with compound <b>4d</b>.</p>","PeriodicalId":7389,"journal":{"name":"Advances in Pharmacological Sciences","volume":"2019 ","pages":"5964687"},"PeriodicalIF":0.0,"publicationDate":"2019-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2019/5964687","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37010519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"GRP78/BIP/HSPA5 as a Therapeutic Target in Models of Parkinson's Disease: A Mini Review.","authors":"Adaze Bijou Enogieru,&nbsp;Sylvester Ifeanyi Omoruyi,&nbsp;Donavon Charles Hiss,&nbsp;Okobi Eko Ekpo","doi":"10.1155/2019/2706783","DOIUrl":"https://doi.org/10.1155/2019/2706783","url":null,"abstract":"<p><p>Parkinson's disease (PD) is a common neurodegenerative disorder characterized by selective loss of dopamine neurons in the substantia nigra pars compacta of the midbrain. Reports from postmortem studies in the human PD brain, and experimental PD models reveal that endoplasmic reticulum (ER) stress is implicated in the pathogenesis of PD. In times of stress, the unfolded or misfolded proteins overload the folding capacity of the ER to induce a condition generally known as ER stress. During ER stress, cells activate the unfolded protein response (UPR) to handle increasing amounts of abnormal proteins, and recent evidence has demonstrated the activation of the ER chaperone GRP78/BiP (78 kDa glucose-regulated protein/binding immunoglobulin protein), which is important for proper folding of newly synthesized and partly folded proteins to maintain protein homeostasis. Although the activation of this protein is essential for the initiation of the UPR in PD, there are inconsistent reports on its expression in various PD models. Consequently, this review article aims to summarize current knowledge on neuroprotective agents targeting the expression of GRP78/BiP in the regulation of ER stress in experimental PD models.</p>","PeriodicalId":7389,"journal":{"name":"Advances in Pharmacological Sciences","volume":"2019 ","pages":"2706783"},"PeriodicalIF":0.0,"publicationDate":"2019-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2019/2706783","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37122128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"<i>Gnidia glauca</i>- and <i>Plumbago zeylanica</i>-Mediated Synthesis of Novel Copper Nanoparticles as Promising Antidiabetic Agents.","authors":"Dhiraj A Jamdade,&nbsp;Dishantsingh Rajpali,&nbsp;Komal A Joshi,&nbsp;Rohini Kitture,&nbsp;Anuja S Kulkarni,&nbsp;Vaishali S Shinde,&nbsp;Jayesh Bellare,&nbsp;Kaushik R Babiya,&nbsp;Sougata Ghosh","doi":"10.1155/2019/9080279","DOIUrl":"10.1155/2019/9080279","url":null,"abstract":"<p><p>Rapid, eco-friendly, and cost-effective one-pot synthesis of copper nanoparticles is reported here using medicinal plants like <i>Gnidia glauca</i> and <i>Plumbago zeylanica</i>. Aqueous extracts of flower, leaf, and stem of <i>G. glauca</i> and leaves of <i>P. zeylanica</i> were prepared which could effectively reduce Cu²⁺ ions to CuNPs within 5 h at 100°C which were further characterized using UV-visible spectroscopy, field emission scanning electron microscopy, high-resolution transmission electron microscopy, energy dispersive spectroscopy, dynamic light scattering, X-ray diffraction, and Fourier-transform infrared spectroscopy. Further, the CuNPs were checked for antidiabetic activity using porcine pancreatic <i>α</i>-amylase and <i>α</i>-glucosidase inhibition followed by evaluation of mechanism using circular dichroism spectroscopy. CuNPs were found to be predominantly spherical in nature with a diameter ranging from 1 to 5 nm. The phenolics and flavonoids in the extracts might play a critical role in the synthesis and stabilization process. Significant change in the peak at ∼1095 cm^-1 corresponding to C-O-C bond in ether was observed. CuNPs could inhibit porcine pancreatic <i>α</i>-amylase up to 30% to 50%, while they exhibited a more significant inhibition of <i>α</i>-glucosidase from 70% to 88%. The mechanism of enzyme inhibition was attributed due to the conformational change owing to drastic alteration of secondary structure by CuNPs. This is the first study of its kind that provides a strong scientific rationale that phytogenic CuNPs synthesized using <i>G. glauca</i> and <i>P. zeylanica</i> can be considered to develop candidate antidiabetic nanomedicine.</p>","PeriodicalId":7389,"journal":{"name":"Advances in Pharmacological Sciences","volume":"2019 ","pages":"9080279"},"PeriodicalIF":0.0,"publicationDate":"2019-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2019/9080279","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37070063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Analysis of <i>In Vitro</i> Osteoblast Culture on Scaffolds for Future Bone Regeneration Purposes in Dentistry.","authors":"Sandra J Gutiérrez-Prieto,&nbsp;Sandra J Perdomo-Lara,&nbsp;José M Diaz-Peraza,&nbsp;Luis Gonzalo Sequeda-Castañeda","doi":"10.1155/2019/5420752","DOIUrl":"10.1155/2019/5420752","url":null,"abstract":"<p><p>One of the main focuses of tissue engineering is to search for tridimensional scaffold materials, complying with nature's properties for tissue regeneration. Determining material biocompatibility is a fundamental step in considering its use. Therefore, the purpose of this study was to analyze osteoblast cell adhesion and viability on different materials to determine which was more compatible for future bone regeneration. Tridimensional structures were fabricated with hydroxyapatite, collagen, and porous silica. The bovine bone was used as material control. Biocompatibility was determined by seeding primary osteoblasts on each tridimensional structure. Cellular morphology was assessed by SEM and viability through confocal microscopy. Osteoblast colonization was observed on all evaluated materials' surface, revealing they did not elicit osteoblast cytotoxicity. Analyses of four different materials studied with diverse compositions and characteristics showed that adhesiveness was best seen for HA and viability for collagen. In general, the results of this investigation suggest these materials can be used in combination, as scaffolds intended for bone regeneration in dental and medical fields.</p>","PeriodicalId":7389,"journal":{"name":"Advances in Pharmacological Sciences","volume":"2019 ","pages":"5420752"},"PeriodicalIF":0.0,"publicationDate":"2019-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2019/5420752","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37064809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effect of \"DXB-2030,\" a Polyherbal Formulation, on Experimental Polycystic Ovary Syndrome Associated with Hyperandrogenism.","authors":"Mohammed Azeemuddin,&nbsp;Suryakanth D Anturlikar,&nbsp;Mallappa Onkaramurthy,&nbsp;Mirza R Baig,&nbsp;Basti K Ashok,&nbsp;Raghavendra P Rao,&nbsp;Mohamed Rafiq,&nbsp;Paramesh Rangesh","doi":"10.1155/2019/8272850","DOIUrl":"https://doi.org/10.1155/2019/8272850","url":null,"abstract":"<p><p>The objective of the present study was to evaluate \"DXB-2030,\" a polyherbal combination of <i>Trigonella foenum-graecum</i>, <i>Aloe vera</i>, <i>Sphaeranthus indicus</i>, <i>Nardostachys jatamansi</i>, and <i>Symplocos racemosa</i> extracts in an experimental model of testosterone propionate (TP), induced polycystic ovary syndrome (PCOS) in female rats. Thirty animals were divided into 3 groups of 10 each; group 1 served as normal control; group 2 was administered with TP and served as positive control; along with TP, group 3 was treated with \"DXB-2030\" at a dose of 100 mg/kg p.o., for 60 days. At the end of the study period, the animals were subjected for the estimation of serum testosterone levels, oral glucose tolerance test (OGTT), weight of the ovaries, estrous cycle, and histopathological evaluation. An in vitro assay on GLUT4 expression was carried out to understand the effect of \"DXB-2030\" on insulin resistance. Results showed that treatment with \"DXB-2030\" reversed the TP-induced changes by increasing the GLUT4 expression and decreasing the body weight, testosterone levels, AUC of glucose in OGTT, and the cystic follicles of the ovaries, thus indicating its beneficial effect in PCOS by ameliorating the metabolic dysfunction and reproductive impairment, which are the pathophysiological conditions associated with PCOS. From the results obtained, it can be concluded that \"DXB-2030\" was effective in the management of experimental PCOS and hence may be recommended in the treatment of PCOS.</p>","PeriodicalId":7389,"journal":{"name":"Advances in Pharmacological Sciences","volume":"2019 ","pages":"8272850"},"PeriodicalIF":0.0,"publicationDate":"2019-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2019/8272850","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37210886","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}